Context Therapeutics Inc. (CNTX) Social Stream



Context Therapeutics Inc. (CNTX): $1.50

0.01 (+0.67%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

D

Add CNTX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#337 of 392

in industry

CONTEXT THERAPEUTICS INC (CNTX) Price Targets From Analysts

Use the tables below to see what analysts covering CONTEXT THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-01-24 1 $10 $10 $10 $1.22 719.67%
2022-11-10 2 $10 $6 $8 $1.22 555.74%
2022-12-09 2 $10 $4 $7 $1.22 473.77%
2023-02-07 1 $4 $4 $4 $1.22 227.87%
2023-10-02 2 $4 $4 $4 $1.22 227.87%
2023-11-10 2 $5 $4 $4.5 $1.22 268.85%
NA 1 $NA $NA $NA $1.22 NA%

Price Target Last Issued NA NA, NA

The Trend in the Analyst Price Target


Over the past 48 weeks, CNTX's average price target has gone up $0.5.

CNTX reports an average of 269.47% for its upside potential over the past 39 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-07 1 4 4 4.0 0.969 312.8%
2023-09-11 2 4 4 4.0 1.080 270.37%
2023-10-02 2 4 4 4.0 1.410 183.69%
2023-11-02 2 5 4 4.5 1.260 257.14%
2023-11-10 2 5 4 4.5 1.063 323.33%

CNTX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

The Trend in the Broker Recommendations


Over the past 18 months, CNTX's average broker recommendation rating improved by 0.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CNTX as an investment opportunity.

  • CONTEXT THERAPEUTICS INC's number of analysts covering the stock is greater than 16.98% of all US stocks.
  • CNTX has a higher average analyst price target than 44.73% of all US stocks.
  • In the context of all US stocks, CONTEXT THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 648.08% of them.
  • CONTEXT THERAPEUTICS INC's variance in analysts' estimates is lower than -4.57% of Pharmaceutical Products stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to CONTEXT THERAPEUTICS INC are IOBT, NVCT, and ACRV.

Is CNTX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!